Pune, India -- (SBWIRE) -- 09/04/2019 -- Global Dutasteride Market Overview:
The Global Dutasteride Market is growing continuously and expected to grow healthy Compound Annual Growth Rate (CAGR) by Forecast year 2023.
According to market research report, Dutasteride is an oral synthetic 4-azasteroid commonly marketed under the trade name Avodart. It is a novel dual 5?-reductase inhibitor that works by blocking both isoforms of 5?-reductase enzymes in a potent, selective, and irreversible manner. Type I and II 5?-reductase enzymes convert testosterone into dihydrotestosterone (DHT), a primary hormonal mediator that plays a role in the development and enlargement of the prostate gland.
Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/155420 .
Dutasteride was approved by the FDA in 2001 for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men as monotherapy or in combination with the ?-adrenergic antagonist tamsulosin to enhance the therapeutic response. Its clinical efficacy against benign prostate hyperplasia in male patients is comparable to that of finasteride, a specific type II 5?-reductase inhibitor. However, unlike finasteride, dutasteride is not yet indicated for the treatment of androgenic alopecia although it was demonstrated to be effective in several randomized, double-blind, placebo-controlled trials in androgenetic alopecia.
The Global Dutasteride Market is segmented on the basis of Type, Application and Region. On the basis of Type, the Global Dutasteride Market is classified into Avodart and Generic Avodart. Based on the Application, the Global Dutasteride Market is sub-segmented into Hospital, Drug store and others.
Current Business News:
1 Teva Pharmaceutical (May 10, 2019) – Teva Announces the Launch of a Generic Version of Delzicol (mesalamine) Delayed-Release Capsules in the United States – Teva Pharmaceutical Industries Ltd. today announced the launch of a generic version of Delzicol (mesalamine) delayed-release capsules, 400 mg, in the U.S.
Mesalamine Delayed-Release Capsules are an aminosalicylate indicated for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older, and for the maintenance of remission of ulcerative colitis in adults.
Teva EVP and Head of North America Commercial, Brendan O'Grady said, "Ulcerative colitis is a chronic inflammatory bowel disease and we're proud to provide another treatment option for patients."
Top Leading Key Manufacturers in Global Dutasteride Market: GSK, Bionpharma, Rising Pharmaceuticals, Teva, Mylan, Zydus, Amneal Pharma, Apotex, Marksans Pharma, Breckenridge Pharmaceutical and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.
With the presence of a large pool of participants, the Global Dutasteride Market is displaying a highly competitive business landscape, finds a new research report by Business Industry Reports (BIR). GSK, Bionpharma, Rising Pharmaceuticals, Teva, Mylan, Zydus, Amneal Pharma, Apotex, Marksans Pharma, Breckenridge Pharmaceutical are some of the key vendors of Dutasteride across the world. These players across Dutasteride Market are focusing aggressively on innovation, as well as on including advanced technologies in their existing products.
Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Dutasteride in these regions, from 2013 to 2023 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America
Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on "Global Dutasteride Market Report 2019" @ https://www.businessindustryreports.com/buy-now/155420/single .
Table of Contents
1 Dutasteride Product Definition
2 Global Dutasteride Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Dutasteride Shipments
2.2 Global Manufacturer Dutasteride Business Revenue
2.3 Global Dutasteride Market Overview
3 Manufacturer Dutasteride Business Introduction
3.1 GSK Dutasteride Business Introduction
3.1.1 GSK Dutasteride Shipments, Price, Revenue and Gross profit 2014-2018
3.1.2 GSK Dutasteride Business Distribution by Region
………………. Request free sample to get a complete Table of Content
About BusinessindustryReports.com
BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.
Media Contact
Business Industry Reports
Pune – India
sales@businessindustryreports.com
+19376349940